People: Novogen Ltd (NVGN.O)

NVGN.O on Consolidated Issue listed on NASDAQ Capital Market

3.29USD
24 Jul 2014
Price Change (% chg)

$0.05 (+1.54%)
Prev Close
$3.24
Open
$3.29
Day's High
$3.29
Day's Low
$3.24
Volume
3,418
Avg. Vol
32,473
52-wk High
$6.84
52-wk Low
$3.09

Search Stocks

Hinze, Mark 

Brief Biography

Mr. Mark G. Hinze, CPA, is Chief Financial Officer of Novogen Ltd since June 18, 2010. He joined the Novogen Group in 1999 and previously held the position of the Group’s Financial Controller. Mr. Hinze holds a Bachelors Degree in Economics from Macquarie University and is a CPA. Mr. Hinze has over 18 years experience in accounting and finance. Prior to joining Novogen Mr. Hinze worked as the Finance and Administration Manager of Alpha Healthcare’s Pathology division. Mr. Hinze was also the Finance Manager for Diagnostic Pathology prior to its sale to Alpha Healthcare.

Basic Compensation

Total Annual Compensation, AUD Long-Term Incentive Plans, AUD All Other, AUD Fiscal Year Total, AUD
286,279 -- 39,624 325,903

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John O'Connor

39,100

Graham Kelly

402,148

Mark Hinze

325,903

Daniel Gold

814,617

Andrew Heaton

--

David Brown

--
As Of 29 Jun 2013
Search Stocks